The Mineralization Density of Iliac Crest Bone from Children with Osteogenesis Imperfecta
Overview
Authors
Affiliations
We studied iliac crest biopsy cores taken from young individuals with osteogenesis imperfecta of several types, and from age-matched normals; the same samples had been used in prior studies using conventional light microscopic histomorphometric procedures. The PMMA blocks were micro-milled to a fine finish, carbon coated, and imaged using backscattered electrons (BSE) in an automated digital scanning electron microscope (SEM). For comparison of BSE signal levels between samples, microscope operation parameters were standardized by reference to halogenated dimethacrylate standards, and recording data from stereological arrays of 512*512 nonoverlapping pixels at 3.5 micrometer separation. All OI types showed higher average mineralization densities than age- and site-matched normals. This is interpreted as the result of the failure in matrix assembly, such that it has a higher water volume fraction available for mineral deposition. Added to the net deficit in bone quantity, the predicted higher stiffness of the more mineralized bone will account for much of the observed 'brittleness' that characterizes this class of genetic disease. The mean mineralization density, which was higher in types III, IV, and V than in type I, appears to be correlated with disease severity.
Farlay D, Cornier M, Rizzo S, Cormier-Daire V, Charpie M, Pinto G JBMR Plus. 2025; 9(2):ziae161.
PMID: 39822213 PMC: 11736749. DOI: 10.1093/jbmrpl/ziae161.
Bone Quality and Mineralization and Effects of Treatment in Osteogenesis Imperfecta.
Misof B, Fratzl-Zelman N Calcif Tissue Int. 2024; 115(6):777-804.
PMID: 39231826 DOI: 10.1007/s00223-024-01263-8.
A Dyadic Nosology for Osteogenesis Imperfecta and Bone Fragility Syndromes 2024.
Sillence D Calcif Tissue Int. 2024; 115(6):873-890.
PMID: 38942908 PMC: 11607092. DOI: 10.1007/s00223-024-01248-7.
Gokmen M, Mirioglu A, Kundakci B, Boga I, Bicer O Med Sci Monit. 2024; 30:e944364.
PMID: 38807347 PMC: 11469422. DOI: 10.12659/MSM.944364.
Medical Management for Fracture Prevention in Children with Osteogenesis Imperfecta.
Arundel P, Bishop N Calcif Tissue Int. 2024; 115(6):812-827.
PMID: 38553634 PMC: 11606989. DOI: 10.1007/s00223-024-01202-7.